AVROBIO, Inc. - AVRO

SEC Filings Our AVRO Tweets

About Gravity Analytica

Recent News

  • 11.09.2026 - Tectonic Therapeutic to Participate in Upcoming Investor Conferences
  • 11.06.2026 - Heart Eyes 2: The Valentine’s Slasher Returns
  • 11.05.2026 - Tectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business Highlights
  • 11.04.2026 - Star Wars: Starfighter Stars Ryan Gosling
  • 10.28.2026 - Pikashow | George Michael’s 1988 Faith Tour, Restored
  • 10.23.2026 - Schwarzenegger Plays Santa in Man With The Bag
  • 09.29.2026 - Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
  • 09.03.2026 - Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
  • 08.06.2026 - Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
  • 06.10.2026 - Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients

Recent Filings

  • 11.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 11.05.2026 - EX-99.1 EX-99.1
  • 11.05.2026 - 8-K Current report
  • 10.29.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 10.28.2026 - 4 Statement of changes in beneficial ownership of securities
  • 10.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 10.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 10.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 10.02.2026 - 4 Statement of changes in beneficial ownership of securities
  • 10.02.2026 - 4 Statement of changes in beneficial ownership of securities